Expensify Inc vs Synopsys, Inc. — how do they compare? Expensify Inc trades at $1.78 (market cap $170.21M), while Synopsys, Inc. trades at $419.77 (market cap $81.43B). The key difference: Synopsys, Inc. is far larger — about 478.4× Expensify Inc's market cap, and Expensify Inc is trading nearer its 52-week high, Synopsys, Inc. nearer its low. Which is the better fit depends on your goals.
| EXFY | SNPS | |
|---|---|---|
Market Cap | $170.21M | $81.43B |
Sector | Technology | Technology |
52-Week High | $2.33 | $645.59 |
52-Week Low | $0.75 | $380.47 |
Enterprise Value | $109.24M | $89.79B |
Signals from Pluang's Aura AI — not financial advice
Expensify (EXFY) trades at $1.755, down 3.04% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.04, beating expectations, but maintains negative profitability metrics with a -14.68% net income margin. Recent developments include AI-powered expense management expansions and a $25 million stock repurchase program, indicating strategic initiatives to drive growth.
The outlook remains cautious due to persistent unprofitability despite revenue stabilization around $140 million. Investment opportunities lie in operational efficiency gains and new product integrations, but risks include competitive pressure and the challenge of achieving sustainable profitability. Analyst sentiment is divided with equal buy/hold ratings, reflecting uncertainty about the company's turnaround potential.
Synopsys (SNPS) trades at $425.81, down 1.85% amid bearish technical signals, though it maintains strong analyst support with 82.8% buy ratings and a $559.50 consensus target. The company shows consistent earnings beats and robust revenue growth to $7.05B in 2025, though profitability metrics like net margin (8.91%) and ROE (3.83%) are tempered by high valuations (P/E 97.32). Recent news highlights its strategic pivot to AI-driven design tools and the integration of Ansys, positioning it as a key enabler in the semiconductor ecosystem.
The outlook remains positive given SNPS's strategic positioning in AI and semiconductor design, with significant upside to analyst targets. Risks include execution challenges from the Ansys integration, competitive pressures, and sensitivity to semiconductor cycles. Investors should weigh high valuation multiples against growth potential in the expanding AI market.
Trailing returns across standard periods
Latest headlines on both assets
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →